Andere Sprachen Edwards Lifesciences Corporation Swiss Exchange

Aktien

936853

US28176E1082

EW

Markt geschlossen - Swiss Exchange Andere Börsenplätze 17:35:35 27.06.2019			% 5 Tage	% 1. Jan.
60,6 ^CHF	-1,45 %		-.--%	-.--%

20.06.	Edwards Lifesciences Insider verkaufte Aktien im Wert von $492.258, laut einer aktuellen SEC Einreichung	MT
17.06.	Edwards Lifesciences Corporation kündigt Änderungen in der Geschäftsführung an	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Edwards Lifesciences Insider Sold Shares Worth $492,258, According to a Recent SEC Filing	20.06.
Edwards Lifesciences Corporation Announces Executive Changes	17.06.
Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR	05.06.
Edwards Lifesciences Announces Results from Analysis of Data from Partner Trials Examining Outcomes of Transcatheter Aortic Valve Replacement Patients with Small Annulus	05.06.
Sector Update: Health Care Stocks Steady Premarket Monday	03.06.
Edwards Lifesciences : Autodesk, Gamestop, Nvidia... les valeurs à suivre aujourd'hui à Wall Street -	03.06.
Edwards Lifesciences : cède sa filiale soins intensifs à Becton Dickison	03.06.
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Division for $4.2 Billion in Cash	03.06.
Edwards Lifesciences to sell critical care products unit to Becton Dickinson for $4.2 bln	03.06.
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion	03.06.
BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader	03.06.
Edwards Lifesciences to Sell Critical Care to BD	03.06.
Becton, Dickinson and Company entered into an agreement to acquire Critical Care Product Group of Edwards Lifesciences Corporation (NYSE : EW) for $4.2 billion.	03.06.
EE.UU. - Valores a seguir en Wall Street (actualizado)	31.05.
Edwards Lifesciences : Charter of the Audit Committee	28.05.
Some of the biggest splits in Corporate America	23.05.
Edwards Lifesciences : First Quarter 2024 Fact Sheet	15.05.
Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing	13.05.
Edwards Lifesciences Faces EU Antitrust Complaint By Meril	13.05.
Edwards Lifesciences hit with Meril's EU antitrust complaint	13.05.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Schlagzeilen

Edwards Lifesciences Corporation: Fortlaufende Erfolgsgeschichte

Am 23. April 2024 um 15:40 Uhr